Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.

Rhodes CJ, Batai K, Bleda M, Haimel M, Southgate L, Germain M, Pauciulo MW, Hadinnapola C, Aman J, Girerd B, Arora A, Knight J, Hanscombe KB, Karnes JH, Kaakinen M, Gall H, Ulrich A, Harbaum L, Cebola I, Ferrer J, Lutz K, Swietlik EM, Ahmad F, Amouyel P, Archer SL, Argula R, Austin ED, Badesch D, Bakshi S, Barnett C, Benza R, Bhatt N, Bogaard HJ, Burger CD, Chakinala M, Church C, Coghlan JG, Condliffe R, Corris PA, Danesino C, Debette S, Elliott CG, Elwing J, Eyries M, Fortin T, Franke A, Frantz RP, Frost A, Garcia JGN, Ghio S, Ghofrani HA, Gibbs JSR, Harley J, He H, Hill NS, Hirsch R, Houweling AC, Howard LS, Ivy D, Kiely DG, Klinger J, Kovacs G, Lahm T, Laudes M, Machado RD, MacKenzie Ross RV, Marsolo K, Martin LJ, Moledina S, Montani D, Nathan SD, Newnham M, Olschewski A, Olschewski H, Oudiz RJ, Ouwehand WH, Peacock AJ, Pepke-Zaba J, Rehman Z, Robbins I, Roden DM, Rosenzweig EB, Saydain G, Scelsi L, Schilz R, Seeger W, Shaffer CM, Simms RW, Simon M, Sitbon O, Suntharalingam J, Tang H, Tchourbanov AY, Thenappan T, Torres F, Toshner MR, Treacy CM, Vonk Noordegraaf A, Waisfisz Q, Walsworth AK, Walter RE, Wharton J, White RJ, Wilt J, Wort SJ, Yung D, Lawrie A, Humbert M, Soubrier F, Trégouët DA, Prokopenko I, Kittles R, Gräf S, Nichols WC, Trembath RC, Desai AA, Morrell NW, Wilkins MR; UK NIHR BioResource Rare Diseases Consortium; UK PAH Cohort Study Consortium; US PAH Biobank Consortium.

Lancet Respir Med. 2019 Mar;7(3):227-238. doi: 10.1016/S2213-2600(18)30409-0. Epub 2018 Dec 5.

2.

Canrenone on cardiovascular mortality in congestive heart failure: CanrenOne eFFects on cardiovascular mortality in patiEnts with congEstIve hearT failure: The COFFEE-IT study.

Derosa G, Maffioli P, Scelsi L, Bestetti A, Vanasia M, Cicero AFG, Spinardi L, Bentivenga C, Esposti DD, Caprio M, Borghi C, Pitt B, Cosentino E.

Pharmacol Res. 2019 Mar;141:46-52. doi: 10.1016/j.phrs.2018.11.037. Epub 2018 Nov 28.

PMID:
30502530
3.

Correction: Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension.

Ghio S, Crimi G, Pica S, Temporelli PL, Boffini M, Rinaldi M, Raineri C, Scelsi L, Pistono M, Totaro R, Guida S, Visconti LO.

PLoS One. 2018 Dec 4;13(12):e0208863. doi: 10.1371/journal.pone.0208863. eCollection 2018.

4.

MitraClip procedure as 'bridge to list', the ultimate therapeutic option for end-stage heart failure patients not eligible for heart transplantation due to severe pulmonary hypertension.

Crimi G, Gritti V, Ghio S, Crescio V, Magrini G, Scelsi L, Turco A, Gazzoli F, Ferrario M, Raineri C, Oltrona Visconti L.

Pulm Circ. 2018 Oct-Dec;8(4):2045894018791871. doi: 10.1177/2045894018791871. Epub 2018 Jul 16.

5.

Dobutamine stress echocardiography in pulmonary arterial hypertension.

Ghio S, Fortuni F, Greco A, Turco A, Lombardi C, Scelsi L, Raineri C, Matrone B, Vullo E, Guida S, Badagliacca R, Oltrona Visconti L.

Int J Cardiol. 2018 Nov 1;270:331-335. doi: 10.1016/j.ijcard.2018.06.032. Epub 2018 Jun 8.

PMID:
29903514
6.

Different forms of pulmonary hypertension in a family with clinical and genetic evidence for hereditary hemorrhagic teleangectasia type 2.

Greco A, Plumitallo S, Scelsi L, Maggi G, Sobrero M, Turco A, Raineri C, Arseni N, Cappelletti D, Visconti LO, Pagella F, Spinozzi G, Ghio S, Olivieri C, Danesino C.

Pulm Circ. 2018 Oct-Dec;8(4):2045894018782664. doi: 10.1177/2045894018782664. Epub 2018 May 25.

7.

Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis.

Ammirati E, Cipriani M, Moro C, Raineri C, Pini D, Sormani P, Mantovani R, Varrenti M, Pedrotti P, Conca C, Mafrici A, Grosu A, Briguglia D, Guglielmetto S, Perego GB, Colombo S, Caico SI, Giannattasio C, Maestroni A, Carubelli V, Metra M, Lombardi C, Campodonico J, Agostoni P, Peretto G, Scelsi L, Turco A, Di Tano G, Campana C, Belloni A, Morandi F, Mortara A, Cirò A, Senni M, Gavazzi A, Frigerio M, Oliva F, Camici PG; Registro Lombardo delle Miocarditi.

Circulation. 2018 Sep 11;138(11):1088-1099. doi: 10.1161/CIRCULATIONAHA.118.035319.

8.

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.

Gräf S, Haimel M, Bleda M, Hadinnapola C, Southgate L, Li W, Hodgson J, Liu B, Salmon RM, Southwood M, Machado RD, Martin JM, Treacy CM, Yates K, Daugherty LC, Shamardina O, Whitehorn D, Holden S, Aldred M, Bogaard HJ, Church C, Coghlan G, Condliffe R, Corris PA, Danesino C, Eyries M, Gall H, Ghio S, Ghofrani HA, Gibbs JSR, Girerd B, Houweling AC, Howard L, Humbert M, Kiely DG, Kovacs G, MacKenzie Ross RV, Moledina S, Montani D, Newnham M, Olschewski A, Olschewski H, Peacock AJ, Pepke-Zaba J, Prokopenko I, Rhodes CJ, Scelsi L, Seeger W, Soubrier F, Stein DF, Suntharalingam J, Swietlik EM, Toshner MR, van Heel DA, Vonk Noordegraaf A, Waisfisz Q, Wharton J, Wort SJ, Ouwehand WH, Soranzo N, Lawrie A, Upton PD, Wilkins MR, Trembath RC, Morrell NW.

Nat Commun. 2018 Apr 12;9(1):1416. doi: 10.1038/s41467-018-03672-4.

9.

Left atrial dilatation in systolic heart failure: a marker of poor prognosis, not just a buffer between the left ventricle and pulmonary circulation.

Rossi A, Dini FL, Agricola E, Faggiano P, Benfari G, Temporelli PL, Cucco C, Scelsi L, Vassanelli C, Ghio S.

J Echocardiogr. 2018 Dec;16(4):155-161. doi: 10.1007/s12574-018-0373-9. Epub 2018 Feb 23.

PMID:
29476388
10.

Functional analysis of a novel ENG variant in a patient with hereditary hemorrhagic telangiectasia (HHT) identifies a new Sp1 binding-site.

Plumitallo S, Ruiz-Llorente L, Langa C, Morini J, Babini G, Cappelletti D, Scelsi L, Greco A, Danesino C, Bernabeu C, Olivieri C.

Gene. 2018 Mar 20;647:85-92. doi: 10.1016/j.gene.2018.01.007. Epub 2018 Jan 4.

PMID:
29305977
11.

[Oral combination therapy for the treatment of patients with pulmonary arterial hypertension: what evidence from long-term studies?]

Pezzuto B, Badagliacca R, Poscia R, Torre R, Ghio S, Scelsi L, Greco A, D'Alto M, Argiento P, Vitulo P, Fedele F, Dario Vizza C.

G Ital Cardiol (Rome). 2017 Dec;18(12):854-861. doi: 10.1714/2815.28469. Italian.

PMID:
29189829
12.

Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension.

Ghio S, Crimi G, Pica S, Temporelli PL, Boffini M, Rinaldi M, Raineri C, Scelsi L, Pistono M, Totaro R, Guida S, Oltrona Visconti L.

PLoS One. 2017 Nov 27;12(11):e0188383. doi: 10.1371/journal.pone.0188383. eCollection 2017. Erratum in: PLoS One. 2018 Dec 4;13(12):e0208863.

13.

Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.

Ghio S, Crimi G, Temporelli PL, Traversi E, La Rovere MT, Cannito A, Vizza D, Scelsi L, Raineri C, Guazzi M, Oltrona Visconti L.

Eur J Heart Fail. 2018 Apr;20(4):725-734. doi: 10.1002/ejhf.1067. Epub 2017 Nov 16.

PMID:
29148140
14.

Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension.

Badagliacca R, Raina A, Ghio S, D'Alto M, Confalonieri M, Correale M, Corda M, Paciocco G, Lombardi C, Mulè M, Poscia R, Scelsi L, Argiento P, Sciomer S, Benza RL, Vizza CD.

J Heart Lung Transplant. 2018 Mar;37(3):365-375. doi: 10.1016/j.healun.2017.08.009. Epub 2017 Aug 26.

PMID:
28912026
15.

RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors.

Hoeper MM, Simonneau G, Corris PA, Ghofrani HA, Klinger JR, Langleben D, Naeije R, Jansa P, Rosenkranz S, Scelsi L, Grünig E, Vizza CD, Chang M, Colorado P, Meier C, Busse D, Benza RL.

Eur Respir J. 2017 Sep 9;50(3). pii: 1602425. doi: 10.1183/13993003.02425-2016. Print 2017 Sep.

16.

ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism.

D'Agostino C, Zonzin P, Enea I, Gulizia MM, Ageno W, Agostoni P, Azzarito M, Becattini C, Bongarzoni A, Bux F, Casazza F, Corrieri N, D'Alto M, D'Amato N, D'Armini AM, De Natale MG, Di Minno G, Favretto G, Filippi L, Grazioli V, Palareti G, Pesavento R, Roncon L, Scelsi L, Tufano A.

Eur Heart J Suppl. 2017 May;19(Suppl D):D309-D332. doi: 10.1093/eurheartj/sux030. Epub 2017 May 2.

17.

Prognostic relevance of pulmonary arterial compliance after therapy initiation or escalation in patients with pulmonary arterial hypertension.

Ghio S, D'Alto M, Badagliacca R, Vitulo P, Argiento P, Mulè M, Tuzzolino F, Scelsi L, Romeo E, Raineri C, Martino L, Tamburino C, Poscia R, Vizza CD.

Int J Cardiol. 2017 Mar 1;230:53-58. doi: 10.1016/j.ijcard.2016.12.099. Epub 2016 Dec 21.

PMID:
28038821
18.

[ANMCO Position paper: Recommendations for the follow-up of patients with pulmonary thromboembolism].

D'Agostino C, Zonzin P, Enea I, Gulizia MM, Ageno W, Agostoni P, Azzarito M, Becattini C, Bongarzoni A, Bux F, Casazza F, Corrieri N, D'Alto M, D'Amato N, D'Armini AM, De Natale MG, Di Minno G, Favretto G, Filippi L, Grazioli V, Palareti G, Pesavento R, Roncon L, Scelsi L, Tufano A.

G Ital Cardiol (Rome). 2016 Sep;17(9 Suppl 1):68S-109. doi: 10.1714/2450.25670. Italian.

PMID:
27869893
19.

Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patients.

Cavagna L, Codullo V, Ghio S, Scirè CA, Guzzafame E, Scelsi L, Rossi S, Montecucco C, Caporali R.

Medicine (Baltimore). 2016 Sep;95(39):e4827. doi: 10.1097/MD.0000000000004827.

20.

Right ventricular recovery during follow-up is associated with improved survival in patients with chronic heart failure with reduced ejection fraction.

Dini FL, Carluccio E, Simioniuc A, Biagioli P, Reboldi G, Galeotti GG, Raineri C, Gargani L, Scelsi L, Mandoli GE, Cannito A, Rossi A, Temporelli PL, Ghio S; Network Labs Ultrasound (NEBULA) in Heart Failure Study Group.

Eur J Heart Fail. 2016 Dec;18(12):1462-1471. doi: 10.1002/ejhf.639. Epub 2016 Sep 20.

21.

Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics.

Favalli V, Disabella E, Molinaro M, Tagliani M, Scarabotto A, Serio A, Grasso M, Narula N, Giorgianni C, Caspani C, Concardi M, Agozzino M, Giordano C, Smirnova A, Kodama T, Giuliani L, Antoniazzi E, Borroni RG, Vassallo C, Mangione F, Scelsi L, Ghio S, Pellegrini C, Zedde M, Fancellu L, Sechi G, Ganau A, Piga S, Colucci A, Concolino D, Di Mascio MT, Toni D, Diomedi M, Rapezzi C, Biagini E, Marini M, Rasura M, Melis M, Nucera A, Guidetti D, Mancuso M, Scoditti U, Cassini P, Narula J, Tavazzi L, Arbustini E.

J Am Coll Cardiol. 2016 Sep 6;68(10):1037-50. doi: 10.1016/j.jacc.2016.05.090.

22.

Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.

Opitz CF, Hoeper MM, Gibbs JS, Kaemmerer H, Pepke-Zaba J, Coghlan JG, Scelsi L, D'Alto M, Olsson KM, Ulrich S, Scholtz W, Schulz U, Grünig E, Vizza CD, Staehler G, Bruch L, Huscher D, Pittrow D, Rosenkranz S.

J Am Coll Cardiol. 2016 Jul 26;68(4):368-78. doi: 10.1016/j.jacc.2016.05.047.

23.

Prognostic value of TAPSE after therapy optimisation in patients with pulmonary arterial hypertension is independent of the haemodynamic effects of therapy.

Ghio S, Pica S, Klersy C, Guzzafame E, Scelsi L, Raineri C, Turco A, Schirinzi S, Visconti LO.

Open Heart. 2016 May 9;3(1):e000408. doi: 10.1136/openhrt-2016-000408. eCollection 2016.

24.

Relationship between electrocardiographic findings and Cardiac Magnetic Resonance phenotypes in patients with Hypertrophic Cardiomyopathy.

Fronza M, Raineri C, Valentini A, Bassi EM, Scelsi L, Buscemi ML, Turco A, Castelli G, Ghio S, Visconti LO.

Int J Cardiol Heart Vasc. 2016 Mar 2;11:7-11. doi: 10.1016/j.ijcha.2016.02.001. eCollection 2016 Jun.

25.

Changes in surface electrocardiogram in patients with chronic thromboembolic pulmonary hypertension undergoing pulmonary endarterectomy. Correlations with hemodynamic and echocardiographic improvements after surgery.

Ghio S, Turco A, Klersy C, Scelsi L, Raineri C, Crescio V, Viscardi A, Grazioli V, Sciortino A, Oltrona Visconti L, D'Armini AM.

J Electrocardiol. 2016 Mar-Apr;49(2):223-30. doi: 10.1016/j.jelectrocard.2015.12.006. Epub 2015 Dec 23.

PMID:
26850496
26.

[The PATENT-1 and CHEST-1 studies].

Casu G, Scelsi L, Morsolini M, D'Armini AM.

G Ital Cardiol (Rome). 2015 Feb;16(2):59-64. doi: 10.1714/1798.19570. Italian. No abstract available.

PMID:
25805087
27.

[Mutation of the lamin A/C gene associated with left ventricular apical hypoplasia: a new phenotype for laminopathies?].

Pica S, Ghio S, Raineri C, Scelsi L, Turco A, Visconti LO.

G Ital Cardiol (Rome). 2014 Dec;15(12):717-9. doi: 10.1714/1718.18778. Italian.

PMID:
25533121
28.

Response to letters regarding article, "Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)".

Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, Grünig E, Staehler G, Rosenkranz S, Halank M, Held M, Lange TJ, Behr J, Klose H, Claussen M, Ewert R, Opitz CF, Vizza CD, Scelsi L, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Coghlan G, Pepke-Zaba J, Schulz U, Gorenflo M, Pittrow D, Hoeper MM.

Circulation. 2014 Sep 16;130(12):e110-2. doi: 10.1161/CIRCULATIONAHA.114.010921. No abstract available.

PMID:
25223780
29.

Prognostic stratification of patients with chronic systolic heart failure using biomarkers and Doppler echocardiography.

Ghio S, Alessandrino G, Albertini R, Klersy C, Girardi B, Maggi G, Pazzano AS, Raineri C, Scelsi L, Visconti LO.

J Cardiovasc Med (Hagerstown). 2014 Jun;15(6):470-5. doi: 10.2459/JCM.0000000000000034.

PMID:
24983266
30.

Analyses of longitudinal and of transverse right ventricular function provide different clinical information in patients with pulmonary hypertension.

Pica S, Ghio S, Tonti G, Camporotondo R, Turco A, Pazzano AS, Scelsi L, Raineri C, Oltrona Visconti L.

Ultrasound Med Biol. 2014 Jun;40(6):1096-103. doi: 10.1016/j.ultrasmedbio.2013.12.005. Epub 2014 Feb 16.

PMID:
24548650
31.

Pulmonary arterial compliance and exercise capacity after pulmonary endarterectomy.

Ghio S, Morsolini M, Corsico A, Klersy C, Mattiucci G, Raineri C, Scelsi L, Vistarini N, Oltrona Visconti L, D'Armini AM.

Eur Respir J. 2014 May;43(5):1403-9. doi: 10.1183/09031936.00195313. Epub 2014 Jan 16.

32.

Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).

Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, Grünig E, Staehler G, Rosenkranz S, Halank M, Held M, Lange TJ, Behr J, Klose H, Claussen M, Ewert R, Opitz CF, Vizza CD, Scelsi L, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Coghlan G, Pepke-Zaba J, Schulz U, Gorenflo M, Pittrow D, Hoeper MM.

Circulation. 2014 Jan 7;129(1):57-65. doi: 10.1161/CIRCULATIONAHA.113.004526. Epub 2013 Sep 30.

PMID:
24081973
33.

Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis.

Dini FL, Ghio S, Klersy C, Rossi A, Simioniuc A, Scelsi L, Genta FT, Cicoira M, Tavazzi L, Temporelli PL.

Int J Clin Pract. 2013 Jul;67(7):656-64. doi: 10.1111/ijcp.12144.

PMID:
23758444
34.

Prognostic relevance of a non-invasive evaluation of right ventricular function and pulmonary artery pressure in patients with chronic heart failure.

Ghio S, Temporelli PL, Klersy C, Simioniuc A, Girardi B, Scelsi L, Rossi A, Cicoira M, Tarro Genta F, Dini FL.

Eur J Heart Fail. 2013 Apr;15(4):408-14. doi: 10.1093/eurjhf/hfs208. Epub 2013 Jan 10.

35.

Pulmonary hypertension and right ventricular dysfunction in left heart disease (group 2 pulmonary hypertension).

Wilson SR, Ghio S, Scelsi L, Horn EM.

Prog Cardiovasc Dis. 2012 Sep-Oct;55(2):104-18. doi: 10.1016/j.pcad.2012.07.007. Review.

PMID:
23009907
36.

Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects.

Diegoli M, Grasso M, Favalli V, Serio A, Gambarin FI, Klersy C, Pasotti M, Agozzino E, Scelsi L, Ferlini A, Febo O, Piccolo G, Tavazzi L, Narula J, Arbustini E.

J Am Coll Cardiol. 2011 Aug 23;58(9):925-34. doi: 10.1016/j.jacc.2011.01.072.

37.

Prevalence and prognostic role of anaemia in patients with acute heart failure and preserved or depressed ventricular function.

Tarantini L, Oliva F, Cantoni S, Cioffi G, Agnoletto V, Alunni G, De Cian F, Di Lenarda A, Lucci D, Pulignano G, Scelsi L, Maggioni AP, Tavazzi L.

Intern Emerg Med. 2013 Mar;8(2):147-55. doi: 10.1007/s11739-011-0601-z. Epub 2011 May 5.

PMID:
21544536
38.

Clinical and prognostic relevance of echocardiographic evaluation of right ventricular geometry in patients with idiopathic pulmonary arterial hypertension.

Ghio S, Pazzano AS, Klersy C, Scelsi L, Raineri C, Camporotondo R, D'Armini A, Visconti LO.

Am J Cardiol. 2011 Feb 15;107(4):628-32. doi: 10.1016/j.amjcard.2010.10.027. Epub 2010 Dec 22.

PMID:
21184990
39.

Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial.

Ghio S, Scelsi L, Latini R, Masson S, Eleuteri E, Palvarini M, Vriz O, Pasotti M, Gorini M, Marchioli R, Maggioni A, Tavazzi L; GISSI-HF investigators.

Eur J Heart Fail. 2010 Dec;12(12):1345-53. doi: 10.1093/eurjhf/hfq172. Epub 2010 Oct 16. Erratum in: Eur J Heart Fail. 2011 Sep;13(9):1042.

40.

Inappropriate exercise-induced increase in pulmonary artery pressure in patients with systemic sclerosis.

D'Alto M, Ghio S, D'Andrea A, Pazzano AS, Argiento P, Camporotondo R, Allocca F, Scelsi L, Cuomo G, Caporali R, Cavagna L, Valentini G, Calabrò R.

Heart. 2011 Jan;97(2):112-7. doi: 10.1136/hrt.2010.203471. Epub 2010 Oct 3.

PMID:
20889989
41.

Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.

Cavagna L, Caporali R, Klersy C, Ghio S, Albertini R, Scelsi L, Moratti R, Bonino C, Montecucco C.

J Rheumatol. 2010 Oct;37(10):2064-70. doi: 10.3899/jrheum.090997. Epub 2010 Jul 15.

PMID:
20634241
42.

Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure.

St John Sutton M, Ghio S, Plappert T, Tavazzi L, Scelsi L, Daubert C, Abraham WT, Gold MR, Hassager C, Herre JM, Linde C; REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) Study Group.

Circulation. 2009 Nov 10;120(19):1858-65. doi: 10.1161/CIRCULATIONAHA.108.818724. Epub 2009 Oct 26.

PMID:
19858419
43.

Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy.

Leonardi S, Raineri C, De Ferrari GM, Ghio S, Scelsi L, Pasotti M, Tagliani M, Valentini A, Dore R, Raisaro A, Arbustini E.

Eur Heart J. 2009 Aug;30(16):2003-10. doi: 10.1093/eurheartj/ehp152. Epub 2009 May 27.

PMID:
19474054
44.

Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial.

Ghio S, Freemantle N, Scelsi L, Serio A, Magrini G, Pasotti M, Shankar A, Cleland JG, Tavazzi L.

Eur J Heart Fail. 2009 May;11(5):480-8. doi: 10.1093/eurjhf/hfp034. Epub 2009 Mar 14.

45.

Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension.

Ghio S, Klersy C, Magrini G, D'Armini AM, Scelsi L, Raineri C, Pasotti M, Serio A, Campana C, Viganò M.

Int J Cardiol. 2010 Apr 30;140(3):272-8. doi: 10.1016/j.ijcard.2008.11.051. Epub 2008 Dec 12.

PMID:
19070379
46.

The tailored medical therapy in patients with advanced heart failure referred for cardiac transplantation.

Campana C, Alessandrino G, Striuli L, Agnesina L, Dequarti MC, Ghio S, Scelsi L, Tavazzi L.

Transplant Proc. 2008 Jul-Aug;40(6):1999-2000. doi: 10.1016/j.transproceed.2008.05.044.

PMID:
18675112
47.

Reverse right ventricular remodeling after pulmonary endarterectomy.

D'Armini AM, Zanotti G, Ghio S, Magrini G, Pozzi M, Scelsi L, Meloni G, Klersy C, Viganò M.

J Thorac Cardiovasc Surg. 2007 Jan;133(1):162-8. Epub 2006 Nov 30.

48.

Baseline echocardiographic characteristics of heart failure patients enrolled in a large European multicentre trial (CArdiac REsynchronisation Heart Failure study).

Ghio S, Freemantle N, Serio A, Magrini G, Scelsi L, Pasotti M, Cleland JG, Tavazzi L.

Eur J Echocardiogr. 2006 Oct;7(5):373-8. Epub 2005 Dec 5.

PMID:
16337208
49.

Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure.

Opasich C, Cazzola M, Scelsi L, De Feo S, Bosimini E, Lagioia R, Febo O, Ferrari R, Fucili A, Moratti R, Tramarin R, Tavazzi L.

Eur Heart J. 2005 Nov;26(21):2232-7. Epub 2005 Jun 29.

PMID:
15987710
50.

Epoprostenol in chronic thromboembolic pulmonary hypertension with distal lesions.

Scelsi L, Ghio S, Campana C, D'Armini AM, Serio A, Klersy C, Piovella F, Viganò M, Tavazzi L.

Ital Heart J. 2004 Aug;5(8):618-23.

PMID:
15554033

Supplemental Content

Loading ...
Support Center